|1.||Honma, Y: 3 articles (09/2001 - 08/2000)|
|2.||Tozzi, Maria Grazia: 2 articles (04/2005 - 01/2003)|
|3.||Giannecchini, Michela: 2 articles (04/2005 - 01/2003)|
|4.||Pesi, Rossana: 2 articles (04/2005 - 01/2003)|
|5.||Sgarrella, Francesco: 2 articles (04/2005 - 01/2003)|
|6.||Camici, Marcella: 2 articles (04/2005 - 01/2003)|
|7.||Niitsu, N: 2 articles (09/2000 - 08/2000)|
|8.||Borsarelli, Claudio D: 1 article (11/2013)|
|9.||Thomas, Andrés H: 1 article (11/2013)|
|10.||Serrano, Mariana P: 1 article (11/2013)|
08/15/2000 - "However, previous studies have shown that in the presence of 2'-deoxyadenosine (dAd), human monocytoid leukemia cell lines are much more sensitive to dCF with regard to the inhibition of cell proliferation. "
11/01/1998 - "When cells were incubated in the presence of both dCF and 2'-deoxyadenosine (dAd), the concentration of dCF required to induce apoptosis of monocytoid leukemia cells was much lower than that required for myeloid, erythroid, or lymphoma cell lines. "
09/01/2000 - "Although 2'-deoxycoformycin (dCF) has been reported in clinical trials to be less effective against myeloid than lymphoid malignancies, it may be useful for treating monocytic leukemia with the aid of 2'-deoxyadenosine (dAd) analogs. "
06/01/1990 - "Mycoplasma contamination alters 2'-deoxyadenosine metabolism in deoxycoformycin-treated mouse leukemia cells."
11/01/1982 - "Leukemic cells incubated in vitro with 2'-deoxyadenosine (dAdo) plus an inhibitor of adenosine deaminase, 2'-deoxy-coformycin (DCF), show different metabolic responses depending on the histologic and immunologic type of the leukemia. "
02/01/2009 - "The corresponding modifications of thymidine and 2'-deoxyadenosine have not been assessed, though significant mutations at A:T base pairs were found in the p53 tumor suppressor gene in human gastrointestinal tumors and in shuttle vector studies. "
02/01/2012 - "Nucleoside analogues are used widely for the treatment of viral diseases and cancer, however the preparation of some important intermediates of these nucleoside analogues, including 2'-deoxyadenosine (dAR) and 5-methyluridine (5-MU), remains inconvenient. "
06/01/2009 - "This study examined the roles of human nucleoside transporters (hNTs) in mediating transepithelial fluxes of adenosine, 2'-deoxyadenosine, and three purine nucleoside anti-cancer drugs across polarized monolayers of human renal proximal tubule cells (hRPTCs), which were shown in previous studies to have human equilibrative NT 1 (hENT1) and 2 (hENT2) and human concentrative NT 3 (hCNT3) activities (11). "
11/01/1983 - "Taylor, Cancer Res., 41: 5141-5150, 1981) prompted a flow cytometric analysis of the cell cycle effects of three other adenosine analogues with known effects on polyadenylated RNA metabolism in an attempt to further explore the nature of 2'-deoxyadenosine 5'-triphosphate-mediated lymphotoxicity. "
02/01/1967 - "Effect of the N1-oxides of adenosine, 2'-deoxyadenosine, and 3'-deoxyadenosine on tumor growth in vivo."
|4.||Ovarian Neoplasms (Ovarian Cancer)
10/01/1996 - "The sperm function stimulants pentoxifylline, 2-deoxyadenosine, and follicular fluid were used during the sperm preparation of IVF trials for two groups of patients: couples with long-standing infertility and previous IVF failures and couples with male-factor infertility scheduled for their first treatment. "
|9.||DNA (Deoxyribonucleic Acid)